CDP-choline is a naturally occurring compound found in every cell of your body, where it serves as a building block for cell membranes. Also known as citicoline (its official pharmaceutical name) or cytidine-diphosphocholine, it consists of two simpler molecules, choline and cytidine, linked together by a phosphate bridge. Since the 1970s it has been sold as both a prescription medicine and a dietary supplement aimed at supporting brain health, memory, and recovery from neurological injury.
How CDP-Choline Works in the Body
When you take CDP-choline by mouth, your gut immediately breaks it apart into its two components: choline and cytidine. Both are absorbed quickly into the bloodstream. Your liver and other tissues then reassemble them back into CDP-choline, which enters cells throughout the body, including the brain. Choline and cytidine can each cross the blood-brain barrier on their own, so the raw materials reach brain tissue readily.
Once inside neurons, CDP-choline feeds into the production of phosphatidylcholine, the most abundant phospholipid in cell membranes. This matters because healthy membranes keep neurons functioning properly: they regulate what enters and exits the cell, maintain electrical signaling, and house the machinery that produces energy. The downstream products of this pathway, including sphingomyelin, get incorporated directly into neuronal membranes, improving mitochondrial metabolism and overall membrane stability. By restoring phospholipid levels, CDP-choline also appears to influence concentrations of several neurotransmitters, the chemical messengers that carry signals between brain cells.
Effects on Memory and Attention
Most of the human research on CDP-choline focuses on cognition, particularly in middle-aged and older adults. In a randomized, placebo-controlled trial, 250 mg per day for one month improved attention in women aged 40 to 60. A similar result appeared in adolescent males at both 250 and 500 mg per day over 28 days.
Higher doses have shown benefits for memory specifically. In adults aged 50 to 85 who scored below average on memory tests, 1,000 mg per day for three months improved logical memory scores compared to placebo. A separate trial found significant improvement in word and object recall after 1,000 mg daily for just 28 days. Researchers have also tested 500 mg per day in older adults with age-associated memory impairment, a mild decline that falls short of dementia but is noticeable in daily life.
The pattern across studies suggests that lower doses (250 mg) may sharpen attention, while higher doses (500 to 1,000 mg) are typically used when memory improvement is the goal.
Neuroprotective Uses
Beyond everyday cognition, CDP-choline has been studied for its protective effects on injured or degenerating nerve tissue. In stroke models, it reduces the volume of damaged brain tissue and decreases swelling by helping restore the sodium-potassium pumps that keep cells from flooding with water. Clinical stroke trials have reported benefits when it is given soon after blood flow to the brain is interrupted, though it is used as a supportive therapy alongside standard treatment, not a replacement for it.
In glaucoma, where the optic nerve gradually deteriorates, CDP-choline has shown a different kind of neuroprotection. An eight-year study found that adding it to standard eye-pressure-lowering treatment improved both retinal and brain-level visual signals, measured by electrical response tests. Patients also showed gains in their visual field, meaning they could see more of their peripheral environment. These improvements depended on continued treatment: they tended to regress during washout periods when patients stopped taking the supplement. Eye drop formulations have shown similar short-term improvements in retinal cell function.
CDP-Choline vs. Alpha-GPC
Alpha-GPC is the other popular choline supplement, and the two work differently despite sharing a common goal of delivering choline to the brain. Alpha-GPC is 41% choline by weight and converts directly into free choline upon administration, producing nearly double the plasma choline levels of citicoline (25.8 versus 13.1 micromoles per liter). That makes it a more potent raw source of choline for acetylcholine production, the neurotransmitter tied to learning and muscle control.
CDP-choline, by contrast, takes a more indirect route. It goes through several metabolic steps before releasing choline, but it also supplies cytidine, which the body converts into uridine. This gives CDP-choline a dual role: it supports both acetylcholine production and phospholipid synthesis in neuronal membranes. So while alpha-GPC is primarily a cholinergic booster, CDP-choline acts more broadly on membrane structure and cerebral metabolism. The choice between them depends on whether your priority is maximizing choline delivery or getting the broader membrane-support effects.
Safety and Side Effects
CDP-choline has a strong safety record. It displays negligible toxicity at the doses used in research, and clinical trial data consistently shows that the rate of adverse events is comparable to placebo. The most commonly reported issues are mild digestive disturbances, things like nausea or stomach discomfort with oral supplementation.
A meta-analysis covering over 1,600 actively treated patients and nearly 700 placebo-treated patients found no significant difference in side effects between groups. Even in elderly stroke patients, the compound lacked meaningful adverse events. One caution: there is limited data on how liver or kidney impairment might affect its safety profile, and people with kidney failure could theoretically face elevated phosphate levels given the compound’s phosphate-containing structure.
Typical Dosing in Research
Studies have used a fairly wide range. For attention and focus, 250 mg per day has been effective in trials lasting about one month. For memory support in older adults, researchers have used 500 mg to 1,000 mg per day, with trial durations ranging from 28 days to three months. The compound is available as capsules, tablets, and oral solutions, and research comparing oral to injected forms has found similar results in visual function outcomes, suggesting that oral supplementation is effective for getting it where it needs to go.